Company: MIRA
Filing Date: 2025-06-17
Form Type: PREM14A
Source: 0001641172-25-015340
Chunk: 212

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-06-17
Form: PREM14A
Chunk 212
---
 force majeure
excuse performance for a period of more than six (6) months.

9.9 .
THE PARTIES MAKE NO REPRESENTATION OR WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING, WITHOUT LIMITATION, ANY WARRANTY OF TITLE,
OR MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. THE PARTIES MAKE NO REPRESENTATIONS OR WARRANTIES THAT ANY PRODUCT OR SERVICES
MADE, USED, SOLD OR OTHERWISE DISPOSED OF IS OR WILL BE FREE FROM INFRINGEMENT OF PATENTS, COPYRIGHTS, TRADEMARKS, OR OTHER PROPRIETARY
RIGHTS OF THIRD PARTIES.

9.10 . All notices
required or permitted by this Agreement shall be in writing and shall be given by first class postage pre-paid mail, via electronic mail
with receipt verification, or by facsimile transmission, effective in each case upon the date of mailing or facsimile transmission thereof
to the parties addressed as follows:

| If to Licensor:               |     | If to Licensee:               |
| MIRALOGX LLC                  |     | SKNY PHARMACEUTICALS, INC.    |
| 900 West Platt St., Suite 200 |     | 900 West Platt St., Suite 200 |
| Tampa, FL 33606               |     | Tampa, FL 33606               |
| Attn: CFO                     |     | Attn: CEO                     |

or to such other address as the
party to receive such notice shall have designated by written notice to the other party hereto.

<div align='center'>[ Signatures Begin on Next Page]</div>

IN WITNESS WHEREOF, each
of the Parties has caused this Agreement to be executed by its duly authorized officer as of the day and year first above written.

| MIRALOGX LLC (Licensor)               |                      |
| /s/ Jonny Williams, Jr.               |                      |
| Name:                                 | Jonnie Williams, Jr. |
| Title:                                | Manager              |
| SKNY PHARMACEUTICALS, INC. (Licensee) |                      |
| /s/ Kelly Stackpole                   |                      |
| Name:                                 | Kelly Stackpole      |
| Title:                                | CEO                  |

<div align='center'>SCHEDULE A – PATENT RIGHTS</div>

| Country |     | Application No. |     | Filed     |     | Title                                    |
| WO      |     | PCT/US25/17127  |     |